AstraZeneca ( (AZN) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
AstraZeneca’s recent stock move follows its decision to shift its U.S. ADR listing to the New York Stock Exchange, a move aimed at tapping deeper U.S. investor demand as the country already generates nearly half of its revenue. The change in listing, combined with the company’s strong exposure to the U.S. market, has broadened its investor base and brought fresh attention from Wall Street. As a result, analysts have renewed their coverage and adjusted their price targets, reassessing AstraZeneca’s growth prospects and competitive position within the healthcare sector, which has further supported the positive sentiment around the shares, recently trading near $92.8.
More about AstraZeneca
YTD Price Performance: 0.91%
Average Trading Volume: 6,520,879
Technical Sentiment Signal: Buy
Current Market Cap: $288.8B
For further insights into AZN stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.